Considered together, these data show that small-molecule inhibitors of MEK1 effectively block the proliferative and antiapoptotic action of IGF-1 and enhance the ability of 4-OHT and MIF to induce an ROS-dependent apoptosis in ER+ MCF-7 breast cancer cells. Here, MAP2K1 is linked to breast cancer.